COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT01520870
Brief Title: Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT.

First Submitted : January 18, 2012
First Submitted that Met QC Criteria : January 26, 2012
First Posted : January 30, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : March 14, 2018
Last Update Posted : March 16, 2018